Advanced Search

Pathology/Lab Coding Alert

ICD-10:

V84 to Z15: Don't Expect Big Changes for Genetic Test Results

Published on Thu Dec 06, 2012

Follow one-to-one crosswalk. Despite a major CPT® revamping of genetic test codes (see "81200-81479: Get Ready for Molecular Pathology Overhaul" in this issue), you won’t see a similar change for reporting those test results when you change to ICD-10 on Oct. 1, 2014. In fact, you can expect a direct crosswalk of a few ICD-9 codes to ICD-10 for reporting a limited number of molecular pathology test results. Don’t Identify Gene ICD-9 provides the following limited codes to report some genetic test results: V84.01 -- Genetic susceptibility to malignant neoplasm of breast V84.02 -- … ovary V84.03 -- … prostate V84.04 -- … endometrium V84.09 -- … to other malignant neoplasm V84.81 -- Genetic susceptibility to multiple endocrine neoplasia (MEN) V84.89 -- … to other disease. Each of the preceding codes crosswalks directly to the following codes: Z15.01 -- Genetic susceptibility to malignant neoplasm of breast Z15.02 -- … ovary Z15.03 -- … prostate Z15.04 -- … endometrium Z15.09 -- … to [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more

Other Articles in this issue of

Pathology/Lab Coding Alert

View All